Threat Assessment Brief: Reinfection with SARS-CoV-2: considerations for public health response
Risk assessment
Cases with suspected or possible reinfection with SARS-CoV-2 have been recently reported in different countries. In many of these cases, it is uncertain if the individual’s Polymerase Chain Reaction (PCR) test remained positive for a long period of time following the first episode of infection or whether it represents a true reinfection.
The aim of this Threat Assessment Brief is to elucidate the characteristics and frequency of confirmed SARS-CoV-2 reinfection in the literature, to summarise the findings about SARS-CoV-2 infection and antibody development, and to consider the following questions:
• How can a SARS-CoV-2 reinfection be identified?
• How common are SARS-CoV-2 reinfections?
• What is known about the role of reinfection in onward transmission?
• What do these observations mean for acquired immunity?
Finally, options for public health response are proposed.
The aim of this Threat Assessment Brief is to elucidate the characteristics and frequency of confirmed SARS-CoV-2 reinfection in the literature, to summarise the findings about SARS-CoV-2 infection and antibody development, and to consider the following questions:
• How can a SARS-CoV-2 reinfection be identified?
• How common are SARS-CoV-2 reinfections?
• What is known about the role of reinfection in onward transmission?
• What do these observations mean for acquired immunity?
Finally, options for public health response are proposed.
Publication file
Threat assessment brief: Reinfection with SARS-CoV-2: considerations for public health response
English (590.35 KB - PDF)Related content
Surveillance and monitoring
Share this page